loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 211994 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    ViiV Healthcare

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 VIIV HLTHCARE (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 RX (1)

    filter

    01 DOVATO (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag United Kingdom
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      DOLUTEGRAVIR SODIUM; LAMIVUDINE

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET; ORAL
      EQ 50MG BASE;300MG
      2019-04-08
      211994
      DOVATO
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for FDA Orange Book APPLICATION 211994

      Looking for FDA Orange Book APPLICATION 211994 1

      19

      ViiV Healthcare, based in United Kingdom, is a pharmaceutical company.

      One of their notable products is DOLUTEGRAVIR SODIUM; LAMIVUDINE, with a corresponding application number 211994.

      Regulatory Information RX

      With a dosage strength EQ 50MG BASE;300MG

      Dosage Form Route TABLET; ORAL

      Reference Listed Drug Yes

      Approved since 2019-04-08

      Post Enquiry
      POST ENQUIRY